Premium
Rapid diagnosis of monilethrix using dermoscopy
Author(s) -
Liu CI.,
Hsu CH.
Publication year - 2008
Publication title -
british journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.304
H-Index - 179
eISSN - 1365-2133
pISSN - 0007-0963
DOI - 10.1111/j.1365-2133.2008.08705.x
Subject(s) - general hospital , medicine , citation , dermatology , library science , family medicine , computer science
1 Department of Health and Human Services (HHS), Public Health Service (PHS), Food and Drug Administration (FDA). Over-thecounter drug products containing colloidal silver ingredients or silver salts. Final rule. Fed Regist 1999; 64:44653–8. 2 Gaul LE, Staud AH. Clinical spectroscopy. Seventy cases of generalized argyrosis following organic and colloidal silver medication. JAMA 1935; 104:1387–90. 3 Fisher NM, Marsh E, Lazova R. Scar-localized argyria secondary to silver sulfadiazine cream. J Am Acad Dermatol 2003; 49:730–2. 4 Payne CMER, Bladin C, Colchester ACF et al. Argyria from excessive use of topical silver sulphadiazine. Lancet 1992; 340:126. 5 Wright JB, Lam K, Burell RE. Wound management in an era of increasing bacterial antibiotic resistance: a role for topical silver treatment. Am J Infect Contol 1998; 26:572–7. 6 Buckley WR. Localized argyria. Arch Dermatol 1963; 88:531–9. 7 White JM, Powell AM, Brady K et al. Severe generalized argyria secondary to ingestion of colloidal silver protein. Clin Exp Dermatol 2003; 28:254–6. 8 Pariser RJ. Generalized argyria. Clinicopathological features and histochemical studies. Arch Dermatol 1978; 114:373–7. 9 Maitre S, Jaber K, Perrot JL et al. Increased serum and urinary levels of silver during treatment with topical sulfadiazine (Flammazine ). Ann Dermatol Venereol 2002; 129:217–19.